Anti‐Tumor Immunity Induced by a Ternary Membrane System Derived From Cancer Cells, Dendritic Cells, and Bacteria (Small 50/2023)

Anti‐Tumor Immunity An “ABC” ternary membrane‐derived nanosystem blended from antigen‐presenting mature dendritic cell membranes (“A”), bacterial E. coli cytoplasmic membranes (“B”), and cancer cell membranes (“C”), shows great promise for use as a personalized tumor nanovaccine. ABC nanovaccine elicits immune responses on patient‐derived dendritic cells (DCs) by homologous vaccines and promotes recovery from tumor in murine prophylactic and therapeutic models. More details can be found in article number 2302756 by Yumiao Zhang and co‐workers.